Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

An early-morning rise in blood sugar is common in people with diabetes. Find out more about why it happens and how to prevent ...

In the meantime, Novo Nordisk has responded to the threat from the cut-price fast and long-acting insulins with newer insulins that aim to improve on the performance of the established rivals.

Merilog is the third FDA-approved insulin biosimilar, joining two long-acting biosimilar products approved in 2021.

With the approval, Merilog joins two other long-acting biosimilar insulin products. Perspective from Irl B. Hirsch, MD, MACP The FDA has approved the first rapid-acting biosimilar insulin product ...

Crucially, the long-acting insulin was no worse than Tresiba when it came to rates of hypoglycaemia, when blood glucose levels dip too low, according to statistical comparisons between the drugs.

Sliding scale insulin therapy involves following a chart of insulin dosages. A doctor will help a person with diabetes create this chart based on factors like how their body responds to insulin ...

President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...

It is most effective at managing blood sugar overnight and between meals. While long-acting insulin is slow to reach the bloodstream and has a relatively low peak, it stabilizes the “plateau ...

a DB = double-blind, DM = diabetes mellitus, HbA 1c = glycosylated hemoglobin, MC = multicenter, NPH = isophane insulin human, NR = not recorded, OL = open-label, PG = parallel-group, R = randomized.